.AstraZeneca has actually discussed a very early consider the functionality of its own in-house anti...
.After revealing a stage 3 launch based on good midstage results, iTeos and GSK are actually ultimat...
.The FDA should be much more available as well as joint to let loose a surge in commendations of rar...
.It's an uncommonly occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara The...
.Atea Pharmaceuticals' antiviral has actually stopped working yet another COVID-19 test, yet the bio...
.Neurocrine Biosciences' schizophrenia plan pivot has actually failed. The biotech was actually inca...
.Sanofi has created a late entry to the radioligand gathering, paying 100 million euros ($ 110 milli...
.After F2G's first try to obtain a new class of antifungal to market was wrecked due to the FDA, the...
.Moderna has promised to reduce R&D spending by $1.1 billion by 2027. The decision to retract the...
.Merely 4 months after Sanofi wager $80 thousand in beforehand cash on Fulcrum Therapies' losmapimod...